glp-1 training for providers Wellness @ SMTC Support GLP-1 Essentials - TRC Healthcare

Please contact your Ingredion representative for details specific to your area

SH: I was asked this question at a conference I just spoke at, and I was listening

The active ingredient in Wegovy is semaglutide, a GLP-1 receptor agonist

Cell-based assays for Gs-protein (cAMP production), Gq-protein (intracellular Ca 2+ mobilization) and -arrestin (1 and 2) signalling were used to determine the potency (EC 50

In rare cases, more severe side effects such as pancreatitis may occur

Several potential risks arise from concurrent cannabis and Wegovy use, though robust clinical trial data specifically examining this combination are currently unavailable: Reduced treatment efficacy : The most significant concern is that cannabis-induced appetite stimulation may counteract Wegovy's appetite-suppressing effects, potentially compromising weight loss outcomes